|
|
Clin Exp Immunol. 1987 February; 67(2): 343–351. | PMCID: PMC1542605 |
Characterization of a halothane-induced humoral immune response in rabbits. A H Callis, S D Brooks, T P Roth, A J Gandolfi, and B R Brown Abstract An animal model of halothane-induced liver injury has been developed in the rabbit to study the production of humoral immunity towards a biotransformation intermediate of halothane. Rabbits exposed many times to halothane in a 75% O2/25% N2 atmosphere produce an antibody that cross-reacts with the trifluoroacetyl moiety of trifluoroacetylated rabbit serum albumin (TFA-RSA). The generation of this halothane-induced immunogen is dependent upon high oxygen tension as shown by the minimal anti-TFA antibody response seen in rabbits exposed to halothane in a 14% O2/86% N2 atmosphere. In addition, halothane exposure of rabbits specifically immunized with the metabolite-carrier complex, TFA-RSA, induces a secondary antibody response toward the immunogen. In rabbits, either immunized with TFA-RSA or not, multiple halothane exposures induce populations of antibodies with varying specificities. Evidence suggests that predominance of the metabolic intermediate, the ensuing immunogen, and the subsequent antibody response depends upon the oxygen tension during successive exposures to halothane. These successive exposures could potentially generate many different immunogens resulting in varied antibody specificities. Full text Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (975K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References. These references are in PubMed. This may not be the complete list of references from this article. - Ford DJ, Coyle DE, Harrington JF. Effects of hypersensitivity to a halothane metabolite on halothane-induced liver damage. Anesthesiology. 1984 Feb;60(2):141–143. [PubMed]
- Gandolfi AJ, White RD, Sipes IG, Pohl LR. Bioactivation and covalent binding of halothane in vitro: studies with [3H]- and [14C]halothane. J Pharmacol Exp Ther. 1980 Sep;214(3):721–725. [PubMed]
- Kakade ML, Liener IE. Determination of available lysine in proteins. Anal Biochem. 1969 Feb;27(2):273–280. [PubMed]
- LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
- Mathieu A, Dipadua D, Kahan BD, Galdabini JJ, Mills J. Correlation between specific immunity to a metabolite of halothane and hepatic lesions after multiple exposures. Anesth Analg. 1975 May–Jun;54(3):332–339. [PubMed]
- Moult PJ, Adjukiewicz AB, Gaylarde PM, Sarkany I, Sherlock S. Lymphocyte transformation in halothane-related hepatitis. Br Med J. 1975 Apr 12;2(5962):69–70. [PubMed]
- Neuberger J, Gimson AE, Davis M, Williams R. Specific serological markers in the diagnosis of fulminant hepatic failure associated with halothane anaesthesia. Br J Anaesth. 1983 Jan;55(1):15–19. [PubMed]
- Neuberger J, Mieli-Vergani G, Tredger JM, Davis M, Williams R. Oxidative metabolism of halothane in the production of altered hepatocyte membrane antigens in acute halothane-induced hepatic necrosis. Gut. 1981 Aug;22(8):669–672. [PubMed]
- Neuberger J, Vergani D, Mieli-Vergani G, Davis M, Williams R. Hepatic damage after exposure to halothane in medical personnel. Br J Anaesth. 1981 Nov;53(11):1173–1177. [PubMed]
- Paronetto F, Popper H. Lymphocyte stimulation induced by halothane in patients with hepatitis following exposure to halothane. N Engl J Med. 1970 Aug 6;283(6):277–280. [PubMed]
- Price CD, Gibbs AR, Williams WJ. Halothane macrophage migration inhibtiion factor test in halothane-associated hepatitis. J Clin Pathol. 1977 Apr;30(4):312–316. [PubMed]
- Reves JG, McCracken LE., Jr Hepatic pathology and skin test reactions to trifluoro-acetylated autologous protein after repeated halothane anaesthesia in the guineapig. Br J Anaesth. 1976 May;48(5):419–424. [PubMed]
- Rosenberg PH, Wahlström T. Trifluoroacetic acid and some possible intermediate metabolites of halothane as haptens. Anesthesiology. 1973 Mar;38(3):224–227. [PubMed]
- Satoh H, Fukuda Y, Anderson DK, Ferrans VJ, Gillette JR, Pohl LR. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J Pharmacol Exp Ther. 1985 Jun;233(3):857–862. [PubMed]
- Uehleke H, Hellmer KH, Tabarelli-Poplawski S. Metabolic activation of halothane and its covalent binding to liver endoplasmic proteins in vitro. Naunyn Schmiedebergs Arch Pharmacol. 1973 Aug 24;279(1):39–52. [PubMed]
- Vergani D, Tsantoulas D, Eddleston AL, Davis M, Williams R. Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anaesthesia. Lancet. 1978 Oct 14;2(8094):801–803. [PubMed]
- Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston AL, Davis M, Williams R. Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med. 1980 Jul 10;303(2):66–71. [PubMed]
- Walton B, Dumonde DC, Williams C, Jones D, Strunin JM, Layton JM, Strunin L, Simpson R. Lymphocyte transformation. Absence of increased responses in alleged halothane jaundice. JAMA. 1973 Jul 30;225(5):494–498. [PubMed]
|